Please assess the completion status of the following clinical trial:

Trial Title: Body and Social Behavior

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-35 years old~* Have a same-gender friend willing to participate in the second study session~Exclusion Criteria:~* Are not a student~* Have already received the annual influenza vaccine or had the flu this season~* Report current illness/sickness symptoms, including upper respiratory symptoms~* Report any major medical conditions (e.g., diabetes, asthma)~* Use mood or immune altering medications (e.g., anti-depressants)~* Current regular nicotine/tobacco use (i.e., daily use of cigarettes or e-cigarettes)~* Have an allergy to eggs~* Have had COVID-19 in past two weeks~* Current or history of depression or anxiety~* Have had Guillain-Barre Syndrome~* Are allergic to vaccine or ingredients present in vaccine~* Have had an adverse reaction to a blood draw, including to needles or sight or blood~* Weigh less than 110 pounds~* Are unwilling to be video/audio recorded during the social interaction tasks~* Are unwilling to be unmasked during the social interaction tasks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Influenza Vaccine (Type: EXPERIMENTAL): Experimental group given influenza vaccine (Flulaval)
- Sham Vaccine (Type: PLACEBO_COMPARATOR): The control group given a placebo (saline injection)

Based on this trial design, predict the completion outcome and termination type (if applicable).